Description
Nitroglycerin 2.6mg Tablet contains Nitroglycerin Controlled Release 2.6 mg, a nitrate vasodilator used in the prevention and management of angina pectoris when prescribed by a qualified healthcare professional. Nitroglycerin relaxes vascular smooth muscle, helping widen blood vessels and reduce the workload of the heart. The controlled-release formulation is designed to release the medicine over time; its exact release characteristics should be confirmed against the approved product information.
Nitroglycerin controlled-release Tablets may be prescribed for ongoing angina prevention in selected patients with coronary artery disease. They are not intended to replace emergency treatment for an acute angina attack unless the approved product information specifically states otherwise. Patients should follow their clinician’s instructions for managing sudden chest pain.
CardianCare focuses on cardiac and diabetic healthcare products for doctors, pharmacists, procurement teams and pharmaceutical business partners. Businesses searching for a Nitroglycerin controlled-release 2.6 mg Tablets manufacturer India can enquire about product availability, approved specifications, manufacturing-source details and relevant quality documentation.
For procurement teams evaluating a Nitroglycerin controlled-release 2.6 mg Tablets manufacturer and supplier India, important checks include the exact strength, release profile, product authorization, packaging, batch traceability, shelf life and storage requirements.
2. Key Ingredient
Composition: Nitroglycerin 2.6mg
Nitroglycerin, also known as glyceryl trinitrate, is an organic nitrate and vasodilator. It is converted within the body into nitric oxide-related signalling activity that increases cyclic guanosine monophosphate (cGMP) in vascular smooth muscle. This promotes smooth muscle relaxation and blood vessel dilation.
Nitroglycerin primarily reduces venous return to the heart, lowering cardiac preload and oxygen demand. It can also dilate coronary vessels. These actions can help prevent angina symptoms in patients for whom nitrate therapy is appropriate.
The controlled-release design aims to provide medicine release over a longer period than immediate-release formulations. It should not be assumed to provide the same onset or use as sublingual nitroglycerin products intended for acute chest pain.
Businesses researching a Nitroglycerin 2.6mg pharmaceutical company India should review the product’s approved formulation, release characteristics, labelling, regulatory status and quality documentation.
Companies evaluating a Nitroglycerin 2.6mg medicine manufacturer India should verify the legal manufacturer, applicable product authorization, batch documentation and relevant quality standards before procurement.
3. Key Benefits
Angina prevention: May help prevent episodes of angina in appropriately selected patients when prescribed for ongoing management.
Reduced cardiac workload: Venous dilation can reduce the amount of blood returning to the heart, lowering cardiac preload.
Reduced oxygen demand: Lower cardiac workload can help reduce the heart muscle’s oxygen requirements.
Controlled-release presentation: Provides a controlled-release dosage form intended for ongoing treatment according to the approved product information.
Support for individualized cardiac care: May be included in a broader treatment plan for coronary artery disease when clinically appropriate.
established nitrate mechanism: Uses the vasodilator action of nitroglycerin to support angina management.
The clinical response varies between patients. Controlled-release nitroglycerin is not a cure for coronary artery disease and does not replace other prescribed cardiovascular risk-reduction measures.
Pharmaceutical buyers searching for a Nitroglycerin 2.6mg supplier India should verify product authenticity, approved specifications, availability, shelf life and supporting documentation.
A Nitroglycerin 2.6mg Tablet wholesaler and distributor India enquiry may include stock availability, minimum order quantities, delivery coverage, licensing requirements and applicable commercial terms.
Businesses seeking a Nitroglycerin 2.6mg bulk supplier India should request a formal quotation and confirm packaging specifications, storage conditions, batch traceability and quality documentation.
A Nitroglycerin 2.6mg pharmaceutical distributor India should verify distribution eligibility, product authorization and approved product information before starting commercial activities.
4. How Does It Work?
Nitroglycerin acts as a nitrate vasodilator. Within vascular smooth muscle, its bioactivation promotes nitric oxide-related signalling and increases cGMP, leading to relaxation of blood vessel walls.
Its principal haemodynamic effect is venous dilation, which reduces venous return and the amount of blood the heart must pump. This lowers cardiac preload and myocardial oxygen demand. Coronary vasodilation may also contribute to its antianginal effects.
The controlled-release formulation is designed to release the active ingredient over time. Its dosing schedule and clinical use must follow the approved product information. Nitrate tolerance can develop with continuous exposure, so any dosing schedule or nitrate-free interval must be determined by the prescriber rather than adjusted independently.
5. Directions for Use
Dosage: Take only as prescribed by a qualified doctor. The appropriate dose and schedule depend on the patient’s condition and the approved formulation.
Administration: Follow the product label regarding how to take the controlled-release Tablet. Do not crush, chew or split it unless the approved instructions explicitly allow this.
Regular timing: Follow the prescribed schedule consistently. Do not change the dose or timing without medical advice.
Angina attacks: Do not assume this controlled-release Tablet will provide rapid relief during a sudden angina attack. Follow the emergency plan provided by the treating clinician.
Missed dose: Follow the patient leaflet or ask a pharmacist or doctor. Do not take a double dose to compensate for a missed dose.
Alcohol: Avoid or discuss alcohol use with the doctor, as it may worsen dizziness or low blood pressure.
Monitoring: Attend recommended follow-up appointments and report fainting, severe dizziness or worsening chest pain.
Do not stop or modify treatment without consulting the prescriber. If chest pain is new, severe, persistent or accompanied by breathlessness, sweating, nausea or faintness, seek emergency medical care.
6. Possible Side Effects
Possible side effects include:
Headache
Dizziness or light-headedness
Flushing
Low blood pressure
Weakness
Nausea
Reflex increase in heart rate
Important precautions
Severe hypotension: Marked dizziness, fainting or collapse requires urgent assessment.
Worsening chest pain: New or worsening chest pain needs prompt medical evaluation.
Severe headache: A severe or persistent headache should be discussed with a healthcare professional, especially if accompanied by other concerning symptoms.
Rare serious reactions: Serious allergic reactions or methemoglobinaemia are uncommon but require urgent medical attention if suspected.
Side effects may be more likely when nitroglycerin is combined with other blood-pressure-lowering medicines or alcohol. This list is not exhaustive; consult a healthcare professional about persistent or concerning symptoms.
7. Safety Information
Medical supervision: Use only under the guidance of a qualified healthcare professional.
Contraindications: Follow the approved product information. Nitroglycerin should not be used with phosphodiesterase-5 (PDE-5) inhibitors such as sildenafil, tadalafil or vardenafil, or with riociguat, because the combination can cause a dangerous fall in blood pressure.
Low blood pressure: Use requires careful assessment in patients with hypotension, volume depletion or a tendency to faint.
Cardiovascular conditions: Patients with certain conditions, including severe anaemia, raised intracranial pressure or specific forms of shock, require specialist assessment and may have contraindications to nitrate therapy.
Liver and kidney health: Inform the doctor about liver or kidney disease and follow the product-specific prescribing guidance.
Pregnancy: Use during pregnancy only when a clinician determines that it is necessary after assessing the potential benefits and risks.
Breastfeeding: Seek medical advice before use while breastfeeding.
Drug interactions: Tell the doctor about all medicines and supplements, especially PDE-5 inhibitors, riociguat, antihypertensives and other vasodilators. Alcohol can intensify blood-pressure-lowering effects.
Driving and machinery: Avoid driving or operating machinery if dizziness, blurred vision or light-headedness occurs.
Storage: Store in the original packaging according to the approved product label, away from excessive heat and moisture and out of children’s reach.
This information is educational and does not replace approved prescribing information or individualized medical advice.
8. B2B Pharmaceutical Business Enquiries
CardianCare focuses on cardiac and diabetic healthcare products and provides a contact point for pharmaceutical trade enquiries. Doctors, pharmacists, procurement teams, wholesalers, distributors and eligible business partners can contact the company to enquire about current product availability and applicable commercial arrangements.
Businesses researching a Nitroglycerin 2.6mg PCD pharma franchise India opportunity should confirm directly whether the product and relevant programme are available, including territory eligibility, partner requirements and applicable commercial terms.
For a Nitroglycerin 2.6mg Tablets PCD pharma franchise enquiry, prospective partners can request information about product availability, minimum order quantities, licensing requirements, distribution eligibility and any applicable promotional support.
Companies exploring a Nitroglycerin 2.6mg Tablet PCD franchise should verify programme availability and product eligibility before making investment or promotional commitments.
Businesses evaluating Nitroglycerin 2.6mg third party manufacturing India services should first confirm whether the proposed company offers these arrangements. Due diligence should include manufacturing authorization, applicable GMP compliance, product approvals, controlled-release formulation capabilities and quality documentation.
A Nitroglycerin 2.6mg Tablet third party manufacturer India enquiry should cover the facility’s regulatory status, release-profile specifications, quality systems, batch-release procedures, packaging requirements and contractual responsibilities.
Companies investigating Nitroglycerin 2.6mg contract manufacturing India should confirm service availability and discuss formulation specifications, technical documentation, quality agreements, regulatory responsibilities and commercial feasibility with the proposed manufacturing partner.
Contact CardianCare through its official website to enquire about current product availability, pharmaceutical distribution opportunities and applicable business arrangements. PCD franchise, third-party manufacturing and contract manufacturing services must be confirmed directly before being represented as available.
9. For More Information
For more information about NITROGINA 2.6 Tablet (Nitroglycerin Controlled Release 2.6 mg), click here













Reviews
There are no reviews yet.